data.medicaid.govHand-written summary

ACA Federal Upper Limits

Affordable Care Act Federal Upper Limits for multiple source drugs, based on the weighted average of manufacturer prices reported each month.

Freshness

Last posted
Period covered
Update frequency

Dates as CMS lists them in its catalog.

Columns 14

ColumnWhat it meansType
Product Groupproduct_groupThe following methodology forms a Product Group: Include all innovator (I) and non-innovator (N) pharmaceutically and therapeutically equivalent (A-rated) multiple source drugs when calculating the weighted average of monthly AMPs in a FUL Product Group; Will not include single source (S) drugs when calculating the weighted average of monthly AMPs in a FUL Product Group; Will not include formulations of the drug that are not rated by the FDA as pharmaceutically and therapeutically equivalent to the reference listed drug, (A-rated) in the calculation of the weighted average of monthly AMPs, or apply the FUL to those formulations that are not A-rated, e.g., B-rated drugs; Will use the monthly AMP and AMP units reported and certified by manufacturers to calculate the weighted average of monthly AMPs in a FUL Product Group; and, Will not include the AMP of a terminated drug in the weighted average of monthly AMPs.string
IngredientingredientThe order of ingredients presented in the product labelling.string
StrengthstrengthThe strengths presented in the product labelling.string
DosagedosageThe dosage form of the drug.string
RouterouteThe route of administration of the drug.string
MDR Unit Typemdr_unit_typeThe unit type reported to the CMS Medicaid Drug Rebate Program.string
Weighted Average of AMPsweighted_average_of_ampstext
ACA FULaca_fulThe calculated Federal Upper Limit (FUL) for the group.string
Package Sizepackage_sizeIdentifies the number of billing units in the package quantity from which the pharmacist dispenses.string
NDCndcThe National Drug Code (NDC) is a numerical code maintained by the FDA that includes the labeler code, product code, and package code.string
A-RatedaratedIdentifies if the drug is an A-rated drug, (Yes or No).string
Multiplier Greater Than 175 Percent of Weighted Avg of AMPsmultiplier_greater_than_175_percent_of_weighted_avg_of_ampsACA FUL equals the most current average retail community pharmacies' acquisition cost (NADAC) = Y ACA FUL equals 175 percent of the weighted average of the most recently reported monthly AMPs = N Note: All NDC-11s for a FUL Product Group are included in this file; however, only the (I) and (N), A-rated, multiple source drugs are used to calculate the weighted average of the most recently reported monthly AMPs in a FUL Product Group.string
YearyearThe year in which the FUL was calculated.string
MonthmonthThe month in which the FUL was calculated.string

At a glance

Catalog
data.medicaid.gov
Publisher
Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov
Rows
2,280,950
Columns
14
State column
None found
Topics
Prescription drugs, Spending and use of services
Contact
Medicaid.gov@cms.hhs.gov

API

Free, no key needed. This request returns the first 10 rows as JSON:

https://data.medicaid.gov/api/1/datastore/query/ce4cf49b-a21b-5a53-bbc3-509414940847/0?limit=10

CMS's description

Affordable Care Act Federal Upper Limits (FUL) based on the weighted average of the most recently reported monthly average manufacturer price (AMP) for pharmaceutically and therapeutically equivalent multiple source drug products that are available for purchase by retail community pharmacies on a nationwide basis.

The summary at the top was written by hand from this description. Record id mcd:ce4cf49b-a21b-5a53-bbc3-509414940847. This record as JSON.

Keyboard shortcuts

/
Jump to the search box (or the column filter on a dataset page)
Esc
Clear the search box, or close this panel
↓ ↑
Move through the results from the search box
Enter
Open the highlighted result
?
Show this panel